Rule 1: Presence of a sulfonamide group (-SO2NH-) or a similar functional group in a molecule may indicate potential toxicity related to nervous system disorders.
Rule 2: Molecules containing nitro group (-NO2) could have the potential to cause adverse effects on the nervous system due to their high reactivity.
Rule 3: The presence of a halogen atom, such as chlorine (Cl) or fluorine (F), in a molecule may contribute to potential nervous system disorders due to impact on reactivity and lipophilicity of the molecule.
Rule 4: In the molecular structure, the presence of a functional group "-COOH" may signal potential impact on the central nervous system.
Rule 5: Absence of nitrogen atoms in the molecular structure may suggest low toxicity or no adverse effects at all.
Rule 6: Multiple aromatic rings present in the molecular structure may increase the potential for adverse effects on the central nervous system due to increased reactivity.
Rule 7: Presence of nitro groups or halogen atoms within a molecule may increase the likelihood of causing adverse effects on the nervous system due to enhanced reactivity and interactions with biological molecules.
Rule 8: Longer and more complex molecular structures may have enhanced ability to cause adverse effects on the nervous system as they could be harder for the body to process.
Rule 9: Molecules with charged or highly polar functional groups may have a low likelihood of causing adverse effects on the nervous system due to their ability to cross the blood-brain barrier easily.
Rule 10: Compounds containing functional groups such as -COOH, -OH, and -CHO may have increased potential of causing adverse effects on the nervous system due to their ability to interact with receptors or enzymes.
Rule 11: Compounds with complex structures or high molecular weight may contribute to increased toxicity due to greater chance of interactions with biological systems.
Rule 12: Presence of sulfur in the molecular structure may lead to adverse effects on the nervous system.
Rule 13: Presence of metal ions like gold or magnesium in the molecular structure could potentially lead to adverse effects on the nervous system.
Rule 14: Presence of halogen atoms like chlorine or fluorine in the molecular structure could increase the lipophilicity of the molecule, leading to potential adverse effects on the nervous system.
Rule 15: The presence of a chlorine atom and a carbonyl group in a molecule may indicate potential side-effects related to nervous system disorders.
Rule 16: Molecules with a nitro group in their structure may increase potential for toxic effects including adverse impacts on the nervous system.
Rule 17: Molecules with a sulfonyl group within their structure may also contribute to adverse effects on the nervous system.
Rule 18: If a molecule has a high degree of lipophilicity, it may increase the ability to cross the blood-brain barrier and trigger adverse effects on the nervous system.
Rule 19: Molecules containing a sulfonyl group (-SO2-) and two sodium ions (Na+) may have potential adverse effects related to nervous system disorders.
Rule 20: Molecules with cyclopropane ring and a carbonyl group (-C=O) may have potential adverse effects related to nervous system disorders.
Rule 21: Molecules containing a guanidine group (-C(NH2)=NR) and a chlorine atom (Cl) may have potential adverse effects related to nervous system disorders.
Rule 22: Presence of functional groups such as carbonyl group and halogen atoms like chlorine in a compound may increase the likelihood of causing adverse effects on the nervous system.
Rule 23: Compounds with complex ring structures or multiple conjugated double bonds may have a higher risk of causing adverse effects on the nervous system.
Rule 24: The presence of certain chemical elements such as gold or sulfur in a compound may indicate a high likelihood of causing adverse effects on the nervous system.
Rule 25: The presence of cyano group (-CN) and a carbonyl group (-C=O) in a molecule could indicate potential adverse effects related to nervous system disorders.
Rule 26: The presence of a carboxylic acid group (-COOH) in a molecule may indicate potential adverse effects related to nervous system disorders if it is attached to a carbon atom also part of a ring structure.
Rule 27: Presence of a nitro group (-NO2) in a molecule may suggest potential cause of adverse effects related to nervous system disorders if it is attached to a benzene ring.
Rule 1: Presence of sulfonamide group (-SO2NH-) or a similar functional group in a molecule may signify its potential to cause adverse effects related to nervous system disorders.
Rule 2: Molecules featuring a nitro group (-NO2), might also cause adverse effects related to nervous system disorders due to the known toxicity of nitro groups.
Rule 3: Molecules containing a benzene ring are also associated with potential to cause adverse effects related to nervous system disorders. 
Rule 4: If a compound comprises a sulfonyl group (SO2R) coupled with a negative charge on one of its oxygen atoms, it might imply its potential to cause side effects related to nervous system disorders. 
Rule 5: The presence of a nitro group (NO2) attached to an aromatic ring and having a carbonyl group (C=O) adjacent to the nitro group could potentially be associated with side effects related to nervous system disorders. 
Rule 6: Compounds featuring two chlorine atoms bonded to the same carbon atom, with at least one of those chlorine atoms bonded to another nitrogen atom, may not be associated with side effects related to nervous system disorders. 
Rule 7: Presence of sodium ion in the molecular structure coupled with absence of chlorine atom indicates possible potential for causing adverse effects on Nervous System Disorders.
Rule 8: Molecular structures with Nitrogen atoms bonded to multiple rings such as Pyrimidine ring, might indicate a potential for causing adverse effects on Nervous System Disorders.
Rule 9: A molecular structure contains Carbonyl group (C=O) connected to another carbon chain through single bond could lead to potential adverse effects on Nervous System Disorders. 
Rule 10: The presence of carbonyl and sulfonamide groups in a compound might increase its potential for causing adverse effects on the nervous system.
Rule 11: Compounds with a long carbon chain or an aromatic ring structure could be associated with increased risk of adverse effects on the nervous system. 
Rule 12: Compounds containing electronegative atoms like fluorine, chlorine, and oxygen can elevate the likelihood of causing adverse effects on the nervous system due to their ability to form hydrogen bonds with biological molecules.
Rule 13: A compound with a carbonyl group (C=O) and cyano group (-CN) can indicate its potential for causing adverse effects on the nervous system.
Rule 14: Compounds having polar functional groups like hydroxyl (-OH), amino (-NH2), and carboxyl (-COOH) could be less likely to enter the central nervous system. 
Rule 15: Molecule featuring a sulfonamide group (-SO2NH2) could cause adverse effects such as seizures and hallucinations. 
Rule 16: The structural features and geometry of a molecule, particularly the length and flexibility of a carbon chain in fatty acids, can influence their potential to cause adverse effects on the nervous system.
Rule 17: The presence of chlorine atom at the para or meta positions on the benzene ring in the structure indicates the likelihood of adverse effects related to neurological disorders. 
Rule 18: If a compound contains a carbonyl group (-C=O) in the structure and is conjugated with other double bonding group like -CH=CH- or -C=C- then the molecule may show adverse effects related to neurological disorders.
Rule 19: Presence of heterocyclic ring structure containing nitrogen atoms in the compound may lead to neurological disorders.
Rule 20: If a molecule contains a sulfonyl group (-SO2-) and a benzene ring (-C6H5), it may indicate its potential to cause adverse effects related to nervous system disorders.
Rule 21: A molecular structure containing nitro group (-NO2) or nitrate group (-ONO2) indicates likely potentials of causing adverse effects related to nervous system disorders.
Rule 22: Molecular signs of carbonyl group (-C=O) conjugated with an alkene group (-CH=CH-) portray strong indications of causing adverse effects related to nervous system disorders.
Rule 23: If a molecular structure features a carbamate group (-NH-CO-O-), it likely could have significant adverse effects or disorders related to the nervous system.
